Zobrazeno 1 - 10
of 1 302
pro vyhledávání: '"A. Ryozo Nagai"'
Autor:
Yasuhiro Hitomi, Yasushi Imai, Masanari Kuwabara, Yusuke Oba, Tomoyuki Kabutoya, Kazuomi Kario, Hisaki Makimoto, Takahide Kohro, Eiichi Shiraki, Naoyuki Akashi, Hideo Fujita, Tetsuya Matoba, Yoshihiro Miyamoto, Arihiro Kiyosue, Kenichi Tsujita, Masaharu Nakayama, Ryozo Nagai
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 54, Iss , Pp 101507- (2024)
Background: Polypharmacy is associated with an increased risk of adverse events due to the higher number of drugs used. This is particularly notable in patients with chronic coronary syndrome (CCS), who are known to use a large number of drugs. There
Externí odkaz:
https://doaj.org/article/e8e83462c74b4970b94061b859688c78
Autor:
So Ikebe, Masanobu Ishii, Yasuhiro Otsuka, Taishi Nakamura, Kenichi Tsujita, Tetsuya Matoba, Takahide Kohro, Yusuke Oba, Tomoyuki Kabutoya, Yasushi Imai, Kazuomi Kario, Arihiro Kiyosue, Yoshiko Mizuno, Kotaro Nochioka, Masaharu Nakayama, Takamasa Iwai, Yoshihiro Miyamoto, Hisahiko Sato, Naoyuki Akashi, Hideo Fujita, Ryozo Nagai
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 22, Iss , Pp 200304- (2024)
Externí odkaz:
https://doaj.org/article/9e2f1c0c962b48afb42e3c2abced0098
Autor:
Yuki Taguchi, Takeo Nakaya, Kenichi Aizawa, Yoshiyuki Noguchi, Nobuhiko Maiya, Chisako Iwamoto, Kenichi Ohba, Minoru Sugawara, Masayuki Murata, Ryozo Nagai, Fumi Kano
Publikováno v:
FEBS Open Bio, Vol 14, Iss 4, Pp 695-720 (2024)
The peptide mimetic, NC114, is a promising anticancer compound that specifically kills colorectal cancer cells without affecting normal colon epithelial cells. In our previous study, we observed that NC114 inhibited the Wnt/β‐catenin pathway, with
Externí odkaz:
https://doaj.org/article/2ffa86450f6b42db85fe0bbacf267b30
Autor:
Keita Negishi, Kenichi Aizawa, Takayuki Shindo, Toru Suzuki, Takayuki Sakurai, Yuichiro Saito, Takuya Miyakawa, Masaru Tanokura, Yosky Kataoka, Mitsuyo Maeda, Shota Tomida, Hiroyuki Morita, Norifumi Takeda, Issei Komuro, Kazuomi Kario, Ryozo Nagai, Yasushi Imai
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/426cc58817fe4319a502aa4a7f3cbc93
Autor:
Kazuomi Kario, Ryozo Nagai, Kenichi Tsujita, Yoshihiro Miyamoto, Yasushi Imai, Tomoyuki Kabutoya, Hideo Fujita, Kotaro Nochioka, Koichi Kaikita, Tetsuya Matoba, Arihiro Kiyosue, Taishi Nakamura, Masanobu Ishii, Yasuhiro Otsuka, So Ikebe, Takahide Kohro, Yusuke Oba, Yoshiko Mizuno, Masaharu Nakayama, Takamasa Iwai, Hisahiko Sato, Naoyuki Akashi
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Objective This study aimed to investigate the association between heart failure (HF) severity measured based on brain natriuretic peptide (BNP) levels and future bleeding events after percutaneous coronary intervention (PCI).Background The Academic R
Externí odkaz:
https://doaj.org/article/88638d6b841e4720860f1ced32796c2f
Autor:
So Ikebe, Masanobu Ishii, Yasuhiro Otsuka, Taishi Nakamura, Kenichi Tsujita, Tetsuya Matoba, Takahide Kohro, Yusuke Oba, Tomoyuki Kabutoya, Yasushi Imai, Kazuomi Kario, Arihiro Kiyosue, Yoshiko Mizuno, Kotaro Nochioka, Masaharu Nakayama, Takamasa Iwai, Yoshihiro Miyamoto, Hisahiko Sato, Naoyuki Akashi, Hideo Fujita, Ryozo Nagai
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 18, Iss , Pp 200193- (2023)
Background: Heart failure (HF) is associated with a high bleeding risk after percutaneous coronary intervention (PCI). Additionally, major bleeding events increase the risk of subsequent major adverse cardiac events (MACE). However, whether brain nat
Externí odkaz:
https://doaj.org/article/2a46098edba74b66a2f1f3ead8ed834d
Autor:
Masashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki, Takeshi Kimura, Yoshihisa Nakagawa, Yukio Ozaki, Hiroshi Iwata, Katsumi Miyauchi, Hiroyuki Daida, Satoru Suwa, Ichiro Sakuma, Yosuke Nishihata, Yasushi Saito, Hisao Ogawa, Masunori Matsuzaki, Yasuo Ohashi, Isao Taguchi, Shigeru Toyoda, Teruo Inoue, Ryozo Nagai
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background Aggressive lipid lowering by high-dose statin treatment has been established for the secondary prevention of coronary artery disease (CAD). Regarding the low-density lipoprotein cholesterol (LDL-C) level, however, the “The lower
Externí odkaz:
https://doaj.org/article/6642ab44f17f492ea174d7788fa21916
Autor:
Sho Nishida, Tamaki Ishima, Natsuka Kimura, Daiki Iwami, Ryozo Nagai, Yasushi Imai, Kenichi Aizawa
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 521 (2024)
Tacrolimus (TAC)-induced chronic nephrotoxicity (TAC nephrotoxicity) has a detrimental effect on long-term kidney graft survival. However, the pathogenesis of TAC nephrotoxicity remains largely unknown. We explored it by focusing on metabolic changes
Externí odkaz:
https://doaj.org/article/4c80cb87a3d740c0994e4ff3edf14369
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 4, p 2325 (2024)
Nicotinamide adenine dinucleotide (NAD) is a cofactor in redox reactions and an essential mediator of energy metabolism. The redox balance between NAD+ and NADH affects various diseases, cell differentiation, and aging, and in recent years there has
Externí odkaz:
https://doaj.org/article/b6465b500dc5473bb2411f5490787131
Autor:
Kenichi Aizawa, Akari Ikeda, Shota Tomida, Koki Hino, Yuuki Sugita, Tomoyasu Hirose, Toshiaki Sunazuka, Hiroshi Kido, Shigeyuki Yokoyama, Ryozo Nagai
Publikováno v:
Cells, Vol 13, Iss 1, p 87 (2023)
Heart failure with reduced ejection fraction (HFrEF) is characterized not only by reduced left ventricular ejection fraction (EF) but is also combined with symptoms such as dyspnea, fatigue, and edema. Several pharmacological interventions have been
Externí odkaz:
https://doaj.org/article/975d7b0db66346b6a1d334ceaa63364a